Provided by Tiger Trade Technology Pte. Ltd.

Claritev Corporation

23.72
+2.4111.31%
Post-market: 23.720.00000.00%16:27 EDT
Volume:228.84K
Turnover:5.20M
Market Cap:402.45M
PE:-1.40
High:23.92
Open:21.97
Low:21.32
Close:21.31
52wk High:73.68
52wk Low:11.50
Shares:16.97M
Float Shares:5.67M
Volume Ratio:1.20
T/O Rate:4.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.9879
EPS(LYR):-17.3000
ROE:-646.34%
ROA:1.19%
PB:-1.37
PE(LYR):-1.37

Loading ...

Multiplan Fecha 2º Trimestre Com Lucro E Receita Acima Do Esperado

Reuters
·
Jul 31

Claritev Report Flags Federal Eligibility Issues in Nearly 50% of 2025 no Surprises Act IDR Filings Reviewed

Reuters
·
Jul 30

Claritev Sees no Surprises Act IDR Dispute Initiations Top 5.1 Million Through January 2026

Reuters
·
Jul 30

Claritev Partners with SAVVI Financial on Benefits Decision Support Tool

Reuters
·
Jul 28

Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting

GlobeNewswire
·
Jul 27

Claritev is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 21

Claritev price target raised to $37 from $32 at Canaccord

TIPRANKS
·
Jul 21

Claritev Report Flags 39% Jump in IDR Disputes in H1 2025

Reuters
·
Jul 17

Press Release: Claritev Corporation Announces Second Quarter 2026 Earnings Conference Call

Dow Jones
·
Jul 16

Claritev Schedules Q2 Fiscal 2026 Earnings Conference Call

Reuters
·
Jul 16

Market Chatter: DOJ Expands Antitrust Probe Into Claritev

MT Newswires Live
·
Jul 15

Justice Department expands antitrust probe into Claritev, Bloomberg says

TIPRANKS
·
Jul 15

DOJ Expands Antitrust Probe of Claritev, Bloomberg Reports

MT Newswires Live
·
Jul 15

DOJ expands Claritev antitrust investigation, Bloomberg reports

TIPRANKS
·
Jul 15

Claritev drops 13% to $25.93 following Bloomberg report

TIPRANKS
·
Jul 15

Multiplan Launches Share Buyback Program for up to 5 Million Common Shares

Reuters
·
Jun 26

Claritev management participates in Truist Securities Healthcare Disruptors & Digital Health Conference

Reuters
·
Jun 24

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lantheus (LNTH), GoodRx Holdings (GDRX) and Claritev (CTEV)

TIPRANKS
·
Jun 23

Claritev Corp - Antitrust Grand Jury Proceeding Closed; Claritev Not Under Criminal Investigation as of June 17, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 23

Claritev Corp - Received Civil Investigative Demand From DOJ on May 19; Cooperating Fully With DOJ - SEC Filing

THOMSON REUTERS
·
Jun 23